Sfoglia per Autore
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin IgG and IgA secreting multiple myelomas
1993-01-01 P. CORRADINI; M. BOCCADORO;C. VOENA ; A. PILERI
Detection of circulating tumor cells in multiple myeloma by a PCR-based method.
1993-01-01 CORRADINI P ;VOENA C ;OMEDÉ P ;ASTOLFI M ;BOCCADORO M ;DALLA-FAVERA R ;PILERI A
The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma.
1993-01-01 CORRADINI P ;FERRERO D ;VOENA C ;LADETTO M ;BOCCADORO M ;PILERI A
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
1993-01-01 Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A.
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
1994-01-01 Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M; et al.
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.
1995-01-01 Corradini P; Voena C; Astolfi M; Ladetto M; Tarella C; Boccadoro M; Pileri A
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma.
1996-01-01 Corradini P; Ladetto M; Astolfi M; Voena C; Tarella C; Bacigalupo A; Pileri A
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors.
1997-01-01 VOENA C; M. LADETTO; ASTOLFI M; PROVAN D; GRIBBEN JG; BOCCADORO M; PILERI A; CORRADINI P.
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
1997-01-01 CORRADINI P; ASTOLFI M; CHERASCO C; M. LADETTO; VOENA C; CARACCIOLO D; PILERI A; TARELLA C.
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy.
1999-01-01 MASSAIA M; BORRIONE P; BATTAGLIO S; MARIANI S; BEGGIATO E; NAPOLI P; VOENA C; BIANCHI A; COSCIA M; BESOSTRI B; PEOLA S; EVEN J; NOVERO D; M. BOCCADORO; PILERI A
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
1999-01-01 Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
2001-01-01 Corradini, P.; Voena, C.; Astolfi, M.; Dell'Oro, S.; Pilotti, S.; Arrigoni, G.; Bregni, M.; Pileri, A.; Gianni, A.M.
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system.
2002-01-01 VOENA C; LOCATELLI G; CASTELLINO C; OMED P; M. LADETTO; FERRERO D; ZAPPONE E; PERFETTI V; BOCCADORO M; PILERI A; LUSSO P; VILLA C; MALNATI M; CORRADINI P
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
2002-01-01 CORRADINI P; TARELLA C; OLIVIERI A; GIANNI AM; VOENA C; ZALLIO F; LADETTO M; FALDA M; LUCESOLE M; DODERO A; CICERI F; BENEDETTI F; RAMBALDI A; SAJEVA MR; TRESOLDI M; BORDIGNON C; BREGNI M
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer
2002-01-01 Bregni, Marco; Dodero, Anna; Peccatori, Jacopo; Pescarollo, Alessandra; Bernardi, Massimo; Sassi, Isabella; Voena, Claudia; Zaniboni, Alberto; Bordignon, Claudio; Corradini, Paolo
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy.
2003-01-01 Ladetto M; Drandi D; Volpato F; Astolfi M; Voena C; Compagno M; Novarino A; Pollio B; Addeo A; Ricca I; Falco P; Cavallo F; Vallet S; Corradini P; Pileri A; Tamponi G; Palumbo A; Bertetto O; Boccadoro M; Tarella C
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation.
2003-01-01 VOENA C; MALNATI M; MAJOLINO I; FAGÀ G; MONTEFUSCO V; VILLA C; RIZZO E; SANTORO A; M. LADETTO; BOCCADORO M; LUSSO P; CORRADINI P.
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
2003-01-01 CORRADINI P ;CAVO M ;LOKHORST H ;MARTINELLI G ;TERRAGNA C ;MAJOLINO I ;VALAGUSSA P ;BOCCADORO M ;SAMSON D ;BACIGALUPO A ;RUSSELL N ;MONTEFUSCO V ;VOENA C ;GAHRTON G
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma
2003-01-01 BONELLO L; VOENA C; LADETTO M; BOCCADORO M; PALESTRO G; INGHIRAMI G; R. CHIARLE
Development of a consensus IgH quantitative assay for the detection of minimal residual disease in Chronic Lymphocytic Leukemia using 3’-minor groove binder probes.
2004-01-01 Voena C; Bonello L; Francia di Celle P; Malnati M; Chiarle R; Corradini P; Inghirami G; Palestro G.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile